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Abstract
Objective—Monocyte recruitment and interaction with the endothelium is imperative to vascular
recovery. Tie2 plays a key role in endothelial health and vascular remodeling. We studied
monocyte-mediated Tie2/Angiopoietin signaling following interaction of primary monocytes with
endothelial cells and its role in endothelial cell survival.
Methods and results—The direct interaction of primary monocytes with subconfluent
endothelial cells resulted in transient secretion of Angiopoietin-1 from monocytes and the
activation of endothelial Tie2. This effect was abolished by preactivation of monocytes with
TNFα. While primary monocytes contained high levels of both Angiopoietin 1 and 2, endothelial
cells contained primarily Angiopoietin 2.
Seeding of monocytes on serum starved endothelial cells reduced caspase-3 activity by 46% ±
5.1%, and 52% ± 5.8% after TNFα treatment, and decreased detected single strand DNA levels by
41% ± 4.2% and 40± 3.5% respectively. This protective effect of monocytes on endothelial cells
was reversed by Tie2 silencing with specific siRNA. The anti-apoptotic effect of monocytes was
further supported by the activation of cell survival signaling pathways involving PI3K, STAT3
and AKT.
Conclusions—Monocytes and endothelial cells form a unique Tie2/Angiopoietin-1 signaling
system which effects endothelial cell survival and may play critical a role in vascular remodeling
and homeostasis.
Introduction
Tie2, an endothelial cell (EC)-specific transmembrane receptor tyrosine kinase, is essential
for vascular health. Tie2 mediates vascular remodeling and the survival and apoptosis of EC
from a wide range of vascular beds 1–6, and in the face of varying stimuli including exposure
to TNFα, serum deprivation, oxidized low-density lipoproteins, hyperosmolarity and
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irradiation 2, 3, 5–9. The remodeling endothelium controls a diverse set of activities that
includes control of hemostasis and thrombosis, leukocyte adhesion, transmigration and
proliferation and vascular smooth muscle cell biology 10–18. Circulating monocytes are
among the first to respond to endothelial activation - localizing, binding and passing through
damaged endothelium. Recruited monocytes play a unique role in vascular remodeling and
actively participate in the initiation and progression of angiogenesis 11, 13–17.
Previously we demonstrated that monocyte binding to injured or subconfluent EC can
actively promote endothelial proliferation by activating endothelial Met through a contact-
dependent mechanism 19. We now report on the importance of early monocyte-mediated
secretion of Angiopoietin 1 (Ang-1) and endothelial Tie2 phosphorylation in promoting
survival of subconfluent EC under low nutrient and cytokine stress conditions. These
findings shed new light on the active role of monocytes in the regulation of endothelial
function and may well enhance therapeutic modulation of vascular repair and angiogenesis
in a range of critical diseases.
Methods
Cells
Primary human umbilical vein endothelial cells (HUVEC) were purchased from Cambrex
(Walkersville, MD). Primary monocytes were separated prior to each assay from blood
drawn from healthy male subjects under formal protocols sanctioned by the MIT Committee
on Use of Humans in Experimental Sciences, and separated employing a negative isolation
method (Miltenyi Biotec, Auburn, CA). Monocyte were unactivated following negative
selection as was previously demonstrated by following mRNA levels of TNFα and IL1-β in
freshly isolated monocytes.20 Monocyte separation yield was over 90% and validated
employing FACS analysis with anti CD14-RPE antibodies (DakoCytomation, Carpinteria,
CA). Monocyte viability following negative selection was over >98% as measured by trypan
blue staining.
For starvation induced EC apoptosis, HUVEC were grown to subconfluence (5×104 cells/
cm2) in 3.5 cm tissue culture plates, followed by serum starvation (DMEM, 2% heat
inactivated FBS, 24 hr). Following the initial 24 hr starvation period, cultures were exposed
to a second starvation period in DMEM, 0.5% heat inactivated FBS for 24 hr. When
monocytes were seeded in transwell inserts residing above EC cultures the volume of
medium was increased to allow full submerging of the monocytes. For analysis of
monocytes and EC following coculture assays, monocytes were separated from EC by
repeated washes (PBS, EDTA, 2min) as previously described 19, 21 and the purity of
separated monocytes and EC was verified by FACS analysis as previously described 19.
Measured Tie2 and other target molecules were designated as primarily of endothelial origin
as only trace numbers of monocytes were observed by CD14 FACS analysis following the
separation of monocytes from EC-monocyte cocultures.
Tie2 siRNA silencing and EC survival
The role of endothelial Tie2 in monocyte-induced EC survival was studied though down
regulation of Tie2 expression by siRNA silencing. EC were seeded in 6 cm plates (2×105
cells/plate) in DMEM 10% inactivated FBS without antibiotics. Prior to transfection cells
were washed with transfection medium (Santa Cruz Bio-. technology, Santa Cruz, CA) and
transfected with 60 pmol Tie2 siRNA or control siRNA in transfection reagent (Santa Cruz
Bio-. technology, Santa Cruz, CA) following the manufacturer protocol. Assays employing
monocyte interaction were performed 48 hr following transfection. Cleaved Caspase-3
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activity was measured in HUVEC using a Caspase-Glo assay kit (Promega, WI), and ssDNA
with an apoptosis ELISA kit (Millipore, Bedford, MA).
Western blot and ELISA
10 min prior to cell harvesting cultures were treated with 0.5mM sodium orthovanadate to
preserve phosphorylation. Whole cell extracts of EC and monocytes were separated on
glycin-SDS gels, transferred to PVDF membranes and immunobloted with the indicated
antibodies. Ang-1 and 2 were measured in conditioned medium and cell lysates from
HUVEC and monocytes alone or from cocultures using specific ELISA assays (R&D
Systems, Minneapolis, MN). p-Tie2,Tie2, p-AKT, p-ERK, p-PI3K, p-STAT3, β-actin
antibodies were purchased from Cell Signaling Technology (Beverly, MA).
Data analysis
All assays were performed in minimum of duplicates and repeated at least three times (n =
number of replicates). Data are presented as mean ± SD or ± 20% for log graphs. When
applicable, values were compared by Student’s T-test or ANOVA. P<0.05 was considered to
be statistically significant.
Results
Monocyte contact activates endothelial Tie2
Direct contact of primary monocytes with HUVEC resulted in transient secretion of Ang-1
and activation of endothelial Tie2 as early as 10 min following monocyte addition (Fig 1
a,b). EC Tie2 phosphorylation and Ang-1 levels fell in the following 20 min and increased
again between 45 and 180 min. Measurement of Ang-1 and Ang-2 in conditioned medium
taken from subconfluent EC alone and 10 min following the addition of primary unactivated
monocytes showed over 21 fold increase in Ang-1 in the later (Fig 2 a). Preactivation of
monocytes with TNFα for 30 min prior to their addition to subconfluent EC abolished the
secretion of Ang-1 and resulted in over 60% increase in the levels of Ang-2.
Cell lysates taken from subconfluent HUVEC contained over 8-fold more Ang-2 than
Ang-1. In contrast, primary unactivated monocytes contained Ang-1 and high levels of
Ang-2 (Fig 2 b), suggesting that the early appearance of Ang-1, 10 min following the
addition of primary unactivated monocytes to subconfluent EC, is primarily of monocyte
origin. Analysis of Ang-1 content in non-monocyte peripheral blood mononuclear cells
(PBMC) revealed that the high content of Ang-1 is unique to monocytes (Fig 2 b).
The specific effect of monocytes was further supported by comparing the levels of Ang-1 in
the medium following the addition of primary monocytes to subconfluent EC to that
obtained following the addition of platelet enriched fraction and similar numbers of PBMC
(Fig 2 c). The role of contact in the release of Ang-1 from monocytes was confirmed when
the monocytes added to subconfluent EC were separated by a transwell system. In this case
detectable culture media Ang-1 levels dropped by more than 80% (Fig 2 c). The transwell
system required use of higher volume of medium compared with those used in figure 2 a,
resulting in higher medium/cell ratio and lower Ang-1 concentration (Fig 2c).
Previously we reported the unique kinetics of endothelial ERK1/2 activation following
direct interaction with monocytes 19. The activation of endothelial Tie2 correlated closely
with the activation of endothelial ERK1/2 demonstrating similar activation kinetics at the
early (10 min) and late (45 min) interaction.
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Silencing of EC Tie2 reverses monocyte-induced EC survival
Noble et al 15 reported that primary monocytes induce an anti-apoptotic effect in EC through
a contact-dependent activation of EC bcl-2 homologue A1 expression. Tie2 is a well
characterized mediator of EC cell survival 2, 3, 5. The transient activation of endothelial Tie2
by monocytes led us to investigate the effect of monocyte-mediated activation of EC Tie2
on EC survival. Untreated and siTie2 silenced HUVEC were starved (24 h, DMEM, 2% heat
inactivated FBS) in a 96-well plate followed by a second starvation period in DMEM 0.5%
FBS. Prior to the second starvation period, cultures were left untreated or treated with TNFα
(2 ng/mL, 60 min) followed by 3 washes in starvation medium to remove remaining TNFα.
Monocytes were added in proportional numbers and 23 hr later a luminescent substrate was
applied to the cells (1 hr at 37°C), and the production of a luminescent signal was detected
by a Fluoroskan. Prolonged starvation resulted in 2.4 fold increase in detected caspase-3
activity compared with unstarved cells. The addition of monocyte resulted in a reduction in
apoptosis under starvation and TNFα exposure. Caspase-3 activity fell by 46%± 5.1% and
identical 52%± 5.8% after TNFα exposure. Silencing of endothelial Tie2 reduced the
protective effect of monocytes on apoptosis by 28% and 34% respectively (fig 3 a).
The anti-apoptotic effect of monocytes was further confirmed by the detection of single
stranded DNA (ssDNA) in starved EC using a formamide ssDNA ELISA assay 22. EC were
seeded in 96 wells plate and grown to a density of 1×104 cells/well. Cultures were treated as
described for the cleaved caspase-3 assay and apoptosis was analyzed employing ssDNA
apoptosis ELISA kit (Millipore, Bedford, MA). Prolonged starvation alone, or in the
presence of TNFα, resulted in 3.2± 0.7 and 4.2± 0.2 fold increase in detected ssDNA
compared with unstarved cells. Treatment with monocytes reduced starvation and TNFα
induced apoptosis identically by 41% ± 4.2% and 40± 3.5% respectively. Silencing
endothelial Tie2 reversed the antiapoptotic effect of monocytes making it statistically
insignificant in serum starved EC and 20% lower in TNFα treated EC (Fig 3 b).
Monocyte binding activates PI3k, AKT and STAT3 survival mediated signaling
To characterize further the effect of monocytes on EC survival we followed the changes in
phosphorylation levels of other key cell survival mediators: PI3K, p-AKT and p-STAT3,
following interaction with monocytes (Fig 4). PI3K and AKT are activated in EC
downstream of Tie2 3, 4 and play a pivotal role in EC survival 23–26. STAT3 is activated
downstream of ERK and was suggested to support cell survival in different cell types 27–29.
HUVEC were exposed to starvation-induced apoptosis as described above. Following the
second starvation period, unactivated primary monocytes were seeded over EC in
proportional numbers and removed from cocultures in the indicated time points (Fig 4).
Monocytes induced a gradual increase in pI3K phosphorylation of up to 3 fold over
untreated EC. AKT phosphorylation increased 12 fold, 10 min following direct contact with
monocytes and gradually declined to 3 fold phosphorylation over control. STAT3
phosphorylation was apparent beginning with the second activation of ERK at 45min
resulting in up to 27 fold increase in STAT3 phosphorylation 60 min following addition of
monocytes.
Discussion
Julius Connheim identified the central role of monocytes in inflammation and vascular
biology in the 1880s 30. Since then we have come to appreciate the complexity and
sophistication of monocyte-EC biology in mediating vascular health 15, 31, 32. Activated
monocytes induce a myriad of effects on vascular permeability, recruitment of leukocytes,
elaboration of cytokines and other mediators, and progression to vascular inflammation,
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injury and hyperplasia 33. More recently we demonstrated a counter-balancing effect where
unactivated monocytes restore endothelial health via a direct-contact mechanism, mediated
in part by Met. We now report that upon direct physical interaction with EC primary
unactivated monocytes secret high levels of Ang-1 leading to a transient activation of
endothelial Tie2, and that this activation contributes to the regulation of EC survival.
Monocyte secreted Ang-1 activates EC Tie2
The presence of Ang-1 in the regulatory scheme of Tie-2 can help explain the dynamic
regulation of monocyte-EC interactions. As an EC-specific transmembrane receptor tyrosine
kinase Tie-2 is a prime factor for modulation of vascular biology. Indeed its effects are
ubiquitous throughout the vascular system 1–6, and for a range of pathologic stresses 2, 3, 5–9.
We now report that the kinetics of its regulation may make it even more potent a modulator
of vascular events. Monocytes induce rapid activation of endothelial Tie2 followed by a
secondary more sustained activation, and phosphorylation following a complex, rapidly
responsive dynamic that is mediated by Ang-1.
Ang-1/2 together with Ang-3/4 belongs to a family of oligomeric-secreted glycoproteins
which have been identified as a group of ligands of the tyrosine kinase Tie2 receptor. The
angiopoietin and Tie families play a critical role in vascular remodeling and blood vessel
stabilization. Ang-1 was previously shown to play a key role in organization and maturation
of newly formed vessels 34, 35 and in the promotion of quiescence and survival in adult
vasculature.3, 7, 36 Ang-2 acts as a competitive antagonist to Ang-1 effects with blockage of
Tie2 phosphorylation and activation.37 The addition of primary monocytes to EC resulted in
transient secretion of Ang-1 and activation of EC Tie2. The kinetics of Tie2 phosphorylation
showed rapid decline in phosphrylated Tie2 which did not correlate with the moderate
decline in Ang-1 levels.
Bogdanovic et al previously demonstrated that the addition of Ang-1 (800 ng/ml) induces
40% degradation of EC Tie2 in HUVEC culture after 15 min. 38 This regulation of Tie2 by
Ang-1 may account for the reduction in measured pTie2 following the addition of
monocytes and for the relatively low levels of pTie2 compared with soluble Ang-1
following the first 10 min of coculture.
Ang-1 and Ang-2 are differentially regulated during EC-monocyte interaction
Both Ang-1 and Ang-2 are found in high concentration in primary unactivated monocytes.
Yet, Ang-1 is regulated differently by monocytes and EC, and differently than Ang-2 in
monocytes. While Ang-1 was rapidly secreted into the medium, Ang-2, which could play an
inhibiting role in Tie2 signaling during the interaction of the two cell types, remained in low
concentrations. There is therefore differential regulation by monocytes of Ang-1 and Ang-2
as well as endothelial Ang-2 following direct interaction of the two cell types.
The selective secretion of Ang-1 and Ang-2 may be regulated by monocyte activation state
as preactivation of monocytes with TNFα for 30 min prior to their addition to subconfluent
EC abolished the secretion of Ang-1 and increased the secretion of Ang-2. The role of
monocyte activation in the secretion of Ang-1 is supported further by the secretion of Ang-1
following the direct seeding of monocytes over tissue culture plates (data not shown).
Monocyte Ang-1 induces EC survival through EC Tie2
In the present work we used siRNA silencing of EC Tie2 to demonstrate the role of Ang-1/
Tie2 signaling in monocyte-mediated EC survival. Monocyte contact with EC reduced
cleaved caspase-3 levels as well as single stranded DNA following stress induced by serum
starvation and exposure to TNFα. In a previous study in which soluble Tie2 receptor served
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as a neutralizing competitive antagonist 3 the protective effect of Ang-1 on EC was reversed,
further supporting the role of monocytes/Ang-1 in the regulation of EC survival.
Monocyte interaction with the endothelium in areas of inflammation and ischemia indicate a
putative role for EC-monocyte interaction in the regulation of EC survival.14 Direct
interaction of monocytes with EC protects the latter from serum depravation-induced
apoptosis by up regulation of bcl-2 homologue A1 in EC 15. Neutralization of TNFα and
PECAM1 can reduce A1 expression in EC, but does not eliminate the protective effect of
monocytes and cannot explain the contact dependency of this effect 15. A different
mechanism for the protective effect of Ang-1 was proposed by Dallabrida et al suggesting
that promotion of cardiac and skeletal myocyte survival by Ang-1 is mediated by integrins
rather than Tie2 and results in activation of AKT and ERK42/44. 39 In our experiments
inhibition of Tie2 by siRNA silencing only partially reversed the anti-apoptotic effect of
monocytes indicating that other signaling cascades are acting to protect EC from apoptosis.
Monocyte-derived VEGF promotes endothelial cell survival through the
phosphatidylinositol 3'-kinase/Akt signal transduction pathway.25 Recently our group
reported on the early secretion of hepatocyte growth factor by primary unactivated
monocytes upon contact with EC which may also contribute to the protective effect of
monocytes.19, 40
The In vivo effect of Ang-1 on EC survival was well demonstrated by Chung-Hyun Cho et
al who used a stable Ang-1 variant to promote EC survival in irradiated mouse model.41
Little is known about the interaction of circulating monocytes with the endothelium prior to
their binding and transmigration. The kinetics of Tie2 activation and its dependency on
monocytes interaction should correlate with the time during which the two cell types come
in contact in vivo. Although diapedesis takes place rapidly recent in vivo observations
identified a new mode of monocyte interaction with the endothelium defined as “patrolling”.
This interaction was demonstrated in mouse Ly6Clo monocytes (analogous to CD16+ human
monocytes) and was much slower than cell motility observed during diapedesis.18 The
specific role of human monocytes subsets in the regulation of EC Tie2 is the subject of
future work that will require new negative separation tools to produce inactivated monocyte
subset.
Monocyte interaction with EC differentially activates survival related signaling
There appears to be two phases of survival related signaling during monocytes/EC
interaction - an early phase which correlates with strong Tie2 and AKT phosphorylation and
a less intense late phase that corresponds to STAT3 and PI3K activation. The different
activation kinetics of AKT and PI3K suggests that the initial activation of AKT may be
independent of PI3K. STAT-3-ERK interactions depend upon a range of signals and can
induce an anti-apoptotic effect by transcriptional regulation of Bcl-2, Mcl-1 and c-
IAP2. 42, 43 The expression Bcl-2 by monocyte mediated STAT-3 activation may be part of
the mechanism deriving monocyte-induced cell survival previously described by Noble et
al.15
The present study offers new insight into the complex regulation of EC survival by
monocytes. The secretion of Ang-1 by monocytes upon contact with EC followed by the
activation of endothelial Tie2, and the role this cell-cell interaction plays in endothelial
survival, sheds new light on the role of circulating monocytes in vascular homeostasis. The
new form of monocyte-EC communication using Ang-1/Tie2 signaling may have additional
significance in vascular remodeling and will be the subject of future studies.
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Figure 1. Monocytes secretion of Ang-1 and activation endothelial Tie2
(a) Western blot of endothelial tie2 and ERK showing the kinetics of endothelial Tie2 and
ERK phosphorylation following interaction with primary unactivated monocytes.
(b) Ang-1 levels measured in culture medium of EC-monocyte coculture over 180 min
showing the kinetics of Ang-1 secretion. (n=3, *p<0.01).
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Figure 2. Monocytes differentially secrete Ang-1 following interaction with EC
(a) Levels of Ang-1 and 2 measured in conditioned medium (CM) from EC, EC-M coculture
and EC cocultured with monocytes (M) preactivated with TNFα. (b) Levels of Ang-1 and 2
measured in cell lysate from EC, monocytes (M) and non monocytes PBMC. (c) Levels of
Ang-1 measured in conditioned medium following 10 min of medium conditioning of
subconfluent EC, EC+M, EC + non monocytes PBMC, EC + platelet enriched fraction and
EC + monocytes in transwell. (n=3, *p<0.05).
Schubert et al. Page 11
Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2012 April 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Monocytes reduce starvation and cytokine-induced caspase-3 activity and DNA
degradation
(a) Caspase-3 activity in untreated and siTie2 treated EC following starvation and TNFα
treatment with and without monocytes. (b) Single stranded DNA measured in untreated and
siTie2 treated ECs following TNFα treatment with and without monocytes. (c) Correlation
graph of measured caspase-3 versus measured ssDNA. (n=3, R2=0.9434, *p<0.05)
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Figure 4. Monocyte interaction with EC activates survival signaling mediated by PI3K, AKT and
STAT3
Unactivated monocytes introduced to subconfluent, serum-starved HUVEC in direct contact
induce the activation of survival related signaling molecules PI3K, AKT and STAT3
measured by western blot analysis.
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